Literature DB >> 23873902

Prevalence of chronic diseases at the onset of inflammatory arthritis: a population-based study.

Jennie Ursum1, Joke C Korevaar, Jos W R Twisk, Mike J L Peters, François G Schellevis, Micheal T Nurmohamed, Mark M J Nielen.   

Abstract

OBJECTIVE: Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) patients at disease onset. Previous studies have been mainly performed in established IA patients or they focus on isolated co-morbid diseases. Our aim was to determine the prevalence of chronic diseases at the onset of IA and to determine whether this is different from the number that one might expect based on age and sex. Patients and methods. A nested case-control study from 2001 to 2010 using data from patient electronic medical records in general practice. Totally, 3354 patients with newly diagnosed IA were included. Each patient was matched on age, sex and general practice with two control patients. In total, 121 different chronic diseases were studied.
RESULTS: In total, 70% of the IA patients had at least one chronic disease at the onset of IA, compared with 59% of the control patients (P < 0.001). The highest prevalence in IA patients was found for cardiovascular diseases (35%), musculoskeletal diseases (27%) and neurological diseases (22%). Compared with the control patients, patients with IA had the highest increased risk for musculoskeletal diseases [odds ratio, OR = 1.7 (95% confidence interval: 1.6-19)] and for neurological diseases [OR = 1.6 (1.4-1.7)] at the onset of IA.
CONCLUSION: At the onset of IA, nearly three-quarters of patients with IA had at least one other chronic disease. Since multi-morbidity affects treatment and outcome of the IA patient, these diseases should be taken into account when treating IA patients.

Entities:  

Keywords:  Co-morbidity; disease onset; inflammatory arthritis; prevalence.

Mesh:

Year:  2013        PMID: 23873902     DOI: 10.1093/fampra/cmt037

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

1.  Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis.

Authors:  Didem Erdem Gürsoy; Halise Hande Gezer; Sevtap Acer Kasman; Mehmet Tuncay Duruöz
Journal:  Rheumatol Int       Date:  2022-06-01       Impact factor: 3.580

2.  Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis.

Authors:  Marian van Beers-Tas; Markus Mj Nielen; Jos W R Twisk; Joke Korevaar; D van Schaardenburg
Journal:  RMD Open       Date:  2020-07

3.  Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study.

Authors:  Jennie Ursum; Mark M J Nielen; Jos W R Twisk; Mike J L Peters; François G Schellevis; Michael T Nurmohamed; Joke C Korevaar
Journal:  BMC Fam Pract       Date:  2013-12-23       Impact factor: 2.497

4.  Electronic medical records: the way forward for primary care research?

Authors:  Sara Muller
Journal:  Fam Pract       Date:  2014-03-13       Impact factor: 2.267

5.  The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank.

Authors:  Michael J Cook; Eftychia Bellou; John Bowes; Jamie C Sergeant; Terence W O'Neill; Anne Barton; Suzanne M M Verstappen
Journal:  Rheumatology (Oxford)       Date:  2018-12-01       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.